Protein levels of CLDN10 were restored under Aza treatment in ccRCC cell line MZ1973 and MZ1257, and Aza driven DNMT inhibition was confirmed by reduction in DNMT3A protein levels (Fig. 3f + g). Here, CLDN10 is linked to nonpapillary renal cell carcinoma.